• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Global Insomnia Treatment Drugs Market Size, Status and Forecast 2020-2026

report cover
  • 22 June 2020
  • Healthcare
  • 95 Pages
  • Report Code: 24LS-8616
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Insomnia Treatment Drugs -MARKET ADVISORY SERVICES

This report focuses on the global Insomnia Treatment Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Insomnia Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
F.Hoffman La-Roche AG
Merck & Co. Inc.
Mylan N.V.
Pfizer, Inc.
Pernix Therapeutics
Sanofi S.A.
Takeda Pharmaceutical Company Ltd.
Sumitomo Dainippon Pharma Co., Ltd
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals, Inc.

Market segment by Type, the product can be split into
Prescription Sleep Aids
Over the Counter (OTC) Sleep Aids
Market segment by Application, split into
Hospital
Pharmacy
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Insomnia Treatment Drugs status, future forecast, growth opportunity, key market and key players.
To present the Insomnia Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Insomnia Treatment Drugs are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Insomnia Treatment Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Insomnia Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Prescription Sleep Aids
1.4.3 Over the Counter (OTC) Sleep Aids
1.5 Market by Application
1.5.1 Global Insomnia Treatment Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Pharmacy
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Insomnia Treatment Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Insomnia Treatment Drugs Industry
1.6.1.1 Insomnia Treatment Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Insomnia Treatment Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Insomnia Treatment Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Insomnia Treatment Drugs Market Perspective (2015-2026)
2.2 Insomnia Treatment Drugs Growth Trends by Regions
2.2.1 Insomnia Treatment Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Insomnia Treatment Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Insomnia Treatment Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Insomnia Treatment Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Insomnia Treatment Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Insomnia Treatment Drugs Players by Market Size
3.1.1 Global Top Insomnia Treatment Drugs Players by Revenue (2015-2020)
3.1.2 Global Insomnia Treatment Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Insomnia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Insomnia Treatment Drugs Market Concentration Ratio
3.2.1 Global Insomnia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Insomnia Treatment Drugs Revenue in 2019
3.3 Insomnia Treatment Drugs Key Players Head office and Area Served
3.4 Key Players Insomnia Treatment Drugs Product Solution and Service
3.5 Date of Enter into Insomnia Treatment Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Insomnia Treatment Drugs Historic Market Size by Type (2015-2020)
4.2 Global Insomnia Treatment Drugs Forecasted Market Size by Type (2021-2026)

5 Insomnia Treatment Drugs Breakdown Data by Application (2015-2026)
5.1 Global Insomnia Treatment Drugs Market Size by Application (2015-2020)
5.2 Global Insomnia Treatment Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Insomnia Treatment Drugs Market Size (2015-2020)
6.2 Insomnia Treatment Drugs Key Players in North America (2019-2020)
6.3 North America Insomnia Treatment Drugs Market Size by Type (2015-2020)
6.4 North America Insomnia Treatment Drugs Market Size by Application (2015-2020)

7 Europe
7.1 Europe Insomnia Treatment Drugs Market Size (2015-2020)
7.2 Insomnia Treatment Drugs Key Players in Europe (2019-2020)
7.3 Europe Insomnia Treatment Drugs Market Size by Type (2015-2020)
7.4 Europe Insomnia Treatment Drugs Market Size by Application (2015-2020)

8 China
8.1 China Insomnia Treatment Drugs Market Size (2015-2020)
8.2 Insomnia Treatment Drugs Key Players in China (2019-2020)
8.3 China Insomnia Treatment Drugs Market Size by Type (2015-2020)
8.4 China Insomnia Treatment Drugs Market Size by Application (2015-2020)

9 Japan
9.1 Japan Insomnia Treatment Drugs Market Size (2015-2020)
9.2 Insomnia Treatment Drugs Key Players in Japan (2019-2020)
9.3 Japan Insomnia Treatment Drugs Market Size by Type (2015-2020)
9.4 Japan Insomnia Treatment Drugs Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Insomnia Treatment Drugs Market Size (2015-2020)
10.2 Insomnia Treatment Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Insomnia Treatment Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Insomnia Treatment Drugs Market Size by Application (2015-2020)

11 India
11.1 India Insomnia Treatment Drugs Market Size (2015-2020)
11.2 Insomnia Treatment Drugs Key Players in India (2019-2020)
11.3 India Insomnia Treatment Drugs Market Size by Type (2015-2020)
11.4 India Insomnia Treatment Drugs Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Insomnia Treatment Drugs Market Size (2015-2020)
12.2 Insomnia Treatment Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Insomnia Treatment Drugs Market Size by Type (2015-2020)
12.4 Central & South America Insomnia Treatment Drugs Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 F.Hoffman La-Roche AG
13.1.1 F.Hoffman La-Roche AG Company Details
13.1.2 F.Hoffman La-Roche AG Business Overview and Its Total Revenue
13.1.3 F.Hoffman La-Roche AG Insomnia Treatment Drugs Introduction
13.1.4 F.Hoffman La-Roche AG Revenue in Insomnia Treatment Drugs Business (2015-2020))
13.1.5 F.Hoffman La-Roche AG Recent Development
13.2 Merck & Co. Inc.
13.2.1 Merck & Co. Inc. Company Details
13.2.2 Merck & Co. Inc. Business Overview and Its Total Revenue
13.2.3 Merck & Co. Inc. Insomnia Treatment Drugs Introduction
13.2.4 Merck & Co. Inc. Revenue in Insomnia Treatment Drugs Business (2015-2020)
13.2.5 Merck & Co. Inc. Recent Development
13.3 Mylan N.V.
13.3.1 Mylan N.V. Company Details
13.3.2 Mylan N.V. Business Overview and Its Total Revenue
13.3.3 Mylan N.V. Insomnia Treatment Drugs Introduction
13.3.4 Mylan N.V. Revenue in Insomnia Treatment Drugs Business (2015-2020)
13.3.5 Mylan N.V. Recent Development
13.4 Pfizer, Inc.
13.4.1 Pfizer, Inc. Company Details
13.4.2 Pfizer, Inc. Business Overview and Its Total Revenue
13.4.3 Pfizer, Inc. Insomnia Treatment Drugs Introduction
13.4.4 Pfizer, Inc. Revenue in Insomnia Treatment Drugs Business (2015-2020)
13.4.5 Pfizer, Inc. Recent Development
13.5 Pernix Therapeutics
13.5.1 Pernix Therapeutics Company Details
13.5.2 Pernix Therapeutics Business Overview and Its Total Revenue
13.5.3 Pernix Therapeutics Insomnia Treatment Drugs Introduction
13.5.4 Pernix Therapeutics Revenue in Insomnia Treatment Drugs Business (2015-2020)
13.5.5 Pernix Therapeutics Recent Development
13.6 Sanofi S.A.
13.6.1 Sanofi S.A. Company Details
13.6.2 Sanofi S.A. Business Overview and Its Total Revenue
13.6.3 Sanofi S.A. Insomnia Treatment Drugs Introduction
13.6.4 Sanofi S.A. Revenue in Insomnia Treatment Drugs Business (2015-2020)
13.6.5 Sanofi S.A. Recent Development
13.7 Takeda Pharmaceutical Company Ltd.
13.7.1 Takeda Pharmaceutical Company Ltd. Company Details
13.7.2 Takeda Pharmaceutical Company Ltd. Business Overview and Its Total Revenue
13.7.3 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Introduction
13.7.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Treatment Drugs Business (2015-2020)
13.7.5 Takeda Pharmaceutical Company Ltd. Recent Development
13.8 Sumitomo Dainippon Pharma Co., Ltd
13.8.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
13.8.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview and Its Total Revenue
13.8.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Introduction
13.8.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Treatment Drugs Business (2015-2020)
13.8.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
13.9 Teva Pharmaceutical Industries Ltd.
13.9.1 Teva Pharmaceutical Industries Ltd. Company Details
13.9.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
13.9.3 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Introduction
13.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Treatment Drugs Business (2015-2020)
13.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
13.10 Vanda Pharmaceuticals, Inc.
13.10.1 Vanda Pharmaceuticals, Inc. Company Details
13.10.2 Vanda Pharmaceuticals, Inc. Business Overview and Its Total Revenue
13.10.3 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Introduction
13.10.4 Vanda Pharmaceuticals, Inc. Revenue in Insomnia Treatment Drugs Business (2015-2020)
13.10.5 Vanda Pharmaceuticals, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. Insomnia Treatment Drugs Key Market Segments

Table 2. Key Players Covered: Ranking by Insomnia Treatment Drugs Revenue

Table 3. Ranking of Global Top Insomnia Treatment Drugs Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Insomnia Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Prescription Sleep Aids

Table 6. Key Players of Over the Counter (OTC) Sleep Aids

Table 7. COVID-19 Impact Global Market: (Four Insomnia Treatment Drugs Market Size Forecast Scenarios)

Table 8. Opportunities and Trends for Insomnia Treatment Drugs Players in the COVID-19 Landscape

Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 10. Key Regions/Countries Measures against Covid-19 Impact

Table 11. Proposal for Insomnia Treatment Drugs Players to Combat Covid-19 Impact

Table 12. Global Insomnia Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 13. Global Insomnia Treatment Drugs Market Size by Regions (US$ Million): 2020 VS 2026

Table 14. Global Insomnia Treatment Drugs Market Size by Regions (2015-2020) (US$ Million)

Table 15. Global Insomnia Treatment Drugs Market Share by Regions (2015-2020)

Table 16. Global Insomnia Treatment Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 17. Global Insomnia Treatment Drugs Market Share by Regions (2021-2026)

Table 18. Market Top Trends

Table 19. Key Drivers: Impact Analysis

Table 20. Key Challenges

Table 21. Insomnia Treatment Drugs Market Growth Strategy

Table 22. Main Points Interviewed from Key Insomnia Treatment Drugs Players

Table 23. Global Insomnia Treatment Drugs Revenue by Players (2015-2020) (Million US$)

Table 24. Global Insomnia Treatment Drugs Market Share by Players (2015-2020)

Table 25. Global Top Insomnia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Treatment Drugs as of 2019)

Table 26. Global Insomnia Treatment Drugs by Players Market Concentration Ratio (CR5 and HHI)

Table 27. Key Players Headquarters and Area Served

Table 28. Key Players Insomnia Treatment Drugs Product Solution and Service

Table 29. Date of Enter into Insomnia Treatment Drugs Market

Table 30. Mergers & Acquisitions, Expansion Plans

Table 31. Global Insomnia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 32. Global Insomnia Treatment Drugs Market Size Share by Type (2015-2020)

Table 33. Global Insomnia Treatment Drugs Revenue Market Share by Type (2021-2026)

Table 34. Global Insomnia Treatment Drugs Market Size Share by Application (2015-2020)

Table 35. Global Insomnia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 36. Global Insomnia Treatment Drugs Market Size Share by Application (2021-2026)

Table 37. North America Key Players Insomnia Treatment Drugs Revenue (2019-2020) (Million US$)

Table 38. North America Key Players Insomnia Treatment Drugs Market Share (2019-2020)

Table 39. North America Insomnia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 40. North America Insomnia Treatment Drugs Market Share by Type (2015-2020)

Table 41. North America Insomnia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 42. North America Insomnia Treatment Drugs Market Share by Application (2015-2020)

Table 43. Europe Key Players Insomnia Treatment Drugs Revenue (2019-2020) (Million US$)

Table 44. Europe Key Players Insomnia Treatment Drugs Market Share (2019-2020)

Table 45. Europe Insomnia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 46. Europe Insomnia Treatment Drugs Market Share by Type (2015-2020)

Table 47. Europe Insomnia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 48. Europe Insomnia Treatment Drugs Market Share by Application (2015-2020)

Table 49. China Key Players Insomnia Treatment Drugs Revenue (2019-2020) (Million US$)

Table 50. China Key Players Insomnia Treatment Drugs Market Share (2019-2020)

Table 51. China Insomnia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 52. China Insomnia Treatment Drugs Market Share by Type (2015-2020)

Table 53. China Insomnia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 54. China Insomnia Treatment Drugs Market Share by Application (2015-2020)

Table 55. Japan Key Players Insomnia Treatment Drugs Revenue (2019-2020) (Million US$)

Table 56. Japan Key Players Insomnia Treatment Drugs Market Share (2019-2020)

Table 57. Japan Insomnia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 58. Japan Insomnia Treatment Drugs Market Share by Type (2015-2020)

Table 59. Japan Insomnia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 60. Japan Insomnia Treatment Drugs Market Share by Application (2015-2020)

Table 61. Southeast Asia Key Players Insomnia Treatment Drugs Revenue (2019-2020) (Million US$)

Table 62. Southeast Asia Key Players Insomnia Treatment Drugs Market Share (2019-2020)

Table 63. Southeast Asia Insomnia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 64. Southeast Asia Insomnia Treatment Drugs Market Share by Type (2015-2020)

Table 65. Southeast Asia Insomnia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 66. Southeast Asia Insomnia Treatment Drugs Market Share by Application (2015-2020)

Table 67. India Key Players Insomnia Treatment Drugs Revenue (2019-2020) (Million US$)

Table 68. India Key Players Insomnia Treatment Drugs Market Share (2019-2020)

Table 69. India Insomnia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 70. India Insomnia Treatment Drugs Market Share by Type (2015-2020)

Table 71. India Insomnia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 72. India Insomnia Treatment Drugs Market Share by Application (2015-2020)

Table 73. Central & South America Key Players Insomnia Treatment Drugs Revenue (2019-2020) (Million US$)

Table 74. Central & South America Key Players Insomnia Treatment Drugs Market Share (2019-2020)

Table 75. Central & South America Insomnia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 76. Central & South America Insomnia Treatment Drugs Market Share by Type (2015-2020)

Table 77. Central & South America Insomnia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 78. Central & South America Insomnia Treatment Drugs Market Share by Application (2015-2020)

Table 79. F.Hoffman La-Roche AG Company Details

Table 80. F.Hoffman La-Roche AG Business Overview

Table 81. F.Hoffman La-Roche AG Product

Table 82. F.Hoffman La-Roche AG Revenue in Insomnia Treatment Drugs Business (2015-2020) (Million US$)

Table 83. F.Hoffman La-Roche AG Recent Development

Table 84. Merck & Co. Inc. Company Details

Table 85. Merck & Co. Inc. Business Overview

Table 86. Merck & Co. Inc. Product

Table 87. Merck & Co. Inc. Revenue in Insomnia Treatment Drugs Business (2015-2020) (Million US$)

Table 88. Merck & Co. Inc. Recent Development

Table 89. Mylan N.V. Company Details

Table 90. Mylan N.V. Business Overview

Table 91. Mylan N.V. Product

Table 92. Mylan N.V. Revenue in Insomnia Treatment Drugs Business (2015-2020) (Million US$)

Table 93. Mylan N.V. Recent Development

Table 94. Pfizer, Inc. Company Details

Table 95. Pfizer, Inc. Business Overview

Table 96. Pfizer, Inc. Product

Table 97. Pfizer, Inc. Revenue in Insomnia Treatment Drugs Business (2015-2020) (Million US$)

Table 98. Pfizer, Inc. Recent Development

Table 99. Pernix Therapeutics Company Details

Table 100. Pernix Therapeutics Business Overview

Table 101. Pernix Therapeutics Product

Table 102. Pernix Therapeutics Revenue in Insomnia Treatment Drugs Business (2015-2020) (Million US$)

Table 103. Pernix Therapeutics Recent Development

Table 104. Sanofi S.A. Company Details

Table 105. Sanofi S.A. Business Overview

Table 106. Sanofi S.A. Product

Table 107. Sanofi S.A. Revenue in Insomnia Treatment Drugs Business (2015-2020) (Million US$)

Table 108. Sanofi S.A. Recent Development

Table 109. Takeda Pharmaceutical Company Ltd. Company Details

Table 110. Takeda Pharmaceutical Company Ltd. Business Overview

Table 111. Takeda Pharmaceutical Company Ltd. Product

Table 112. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Treatment Drugs Business (2015-2020) (Million US$)

Table 113. Takeda Pharmaceutical Company Ltd. Recent Development

Table 114. Sumitomo Dainippon Pharma Co., Ltd Business Overview

Table 115. Sumitomo Dainippon Pharma Co., Ltd Product

Table 116. Sumitomo Dainippon Pharma Co., Ltd Company Details

Table 117. Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Treatment Drugs Business (2015-2020) (Million US$)

Table 118. Sumitomo Dainippon Pharma Co., Ltd Recent Development

Table 119. Teva Pharmaceutical Industries Ltd. Company Details

Table 120. Teva Pharmaceutical Industries Ltd. Business Overview

Table 121. Teva Pharmaceutical Industries Ltd. Product

Table 122. Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Treatment Drugs Business (2015-2020) (Million US$)

Table 123. Teva Pharmaceutical Industries Ltd. Recent Development

Table 124. Vanda Pharmaceuticals, Inc. Company Details

Table 125. Vanda Pharmaceuticals, Inc. Business Overview

Table 126. Vanda Pharmaceuticals, Inc. Product

Table 127. Vanda Pharmaceuticals, Inc. Revenue in Insomnia Treatment Drugs Business (2015-2020) (Million US$)

Table 128. Vanda Pharmaceuticals, Inc. Recent Development

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Insomnia Treatment Drugs Market Share by Type: 2020 VS 2026

Figure 2. Prescription Sleep Aids Features

Figure 3. Over the Counter (OTC) Sleep Aids Features

Figure 4. Global Insomnia Treatment Drugs Market Share by Application: 2020 VS 2026

Figure 5. Hospital Case Studies

Figure 6. Pharmacy Case Studies

Figure 7. Others Case Studies

Figure 8. Insomnia Treatment Drugs Report Years Considered

Figure 9. Global Insomnia Treatment Drugs Market Size YoY Growth 2015-2026 (US$ Million)

Figure 10. Global Insomnia Treatment Drugs Market Share by Regions: 2020 VS 2026

Figure 11. Global Insomnia Treatment Drugs Market Share by Regions (2021-2026)

Figure 12. Porter's Five Forces Analysis

Figure 13. Global Insomnia Treatment Drugs Market Share by Players in 2019

Figure 14. Global Top Insomnia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Treatment Drugs as of 2019

Figure 15. The Top 10 and 5 Players Market Share by Insomnia Treatment Drugs Revenue in 2019

Figure 16. North America Insomnia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 17. Europe Insomnia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 18. China Insomnia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 19. Japan Insomnia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. Southeast Asia Insomnia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. India Insomnia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. Central & South America Insomnia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. F.Hoffman La-Roche AG Total Revenue (US$ Million): 2019 Compared with 2018

Figure 24. F.Hoffman La-Roche AG Revenue Growth Rate in Insomnia Treatment Drugs Business (2015-2020)

Figure 25. Merck & Co. Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 26. Merck & Co. Inc. Revenue Growth Rate in Insomnia Treatment Drugs Business (2015-2020)

Figure 27. Mylan N.V. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 28. Mylan N.V. Revenue Growth Rate in Insomnia Treatment Drugs Business (2015-2020)

Figure 29. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 30. Pfizer, Inc. Revenue Growth Rate in Insomnia Treatment Drugs Business (2015-2020)

Figure 31. Pernix Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018

Figure 32. Pernix Therapeutics Revenue Growth Rate in Insomnia Treatment Drugs Business (2015-2020)

Figure 33. Sanofi S.A. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 34. Sanofi S.A. Revenue Growth Rate in Insomnia Treatment Drugs Business (2015-2020)

Figure 35. Takeda Pharmaceutical Company Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 36. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Treatment Drugs Business (2015-2020)

Figure 37. Sumitomo Dainippon Pharma Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018

Figure 38. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Insomnia Treatment Drugs Business (2015-2020)

Figure 39. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 40. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Insomnia Treatment Drugs Business (2015-2020)

Figure 41. Vanda Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 42. Vanda Pharmaceuticals, Inc. Revenue Growth Rate in Insomnia Treatment Drugs Business (2015-2020)

Figure 43. Bottom-up and Top-down Approaches for This Report

Figure 44. Data Triangulation

Figure 45. Key Executives Interviewed

F.Hoffman La-Roche AG

Merck & Co. Inc.

Mylan N.V.

Pfizer, Inc.

Pernix Therapeutics

Sanofi S.A.

Takeda Pharmaceutical Company Ltd.

Sumitomo Dainippon Pharma Co., Ltd

Teva Pharmaceutical Industries Ltd.

Vanda Pharmaceuticals, Inc.

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3159

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase